These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38358191)
1. Assessment of endometrial carcinoma on biopsy as a predictor of final surgical pathology: Are we doing it right? A completed audit cycle and recommendations. Jassar A; Hemali N; Bhatnagar A Indian J Pathol Microbiol; 2024; 67(1):68-73. PubMed ID: 38358191 [TBL] [Abstract][Full Text] [Related]
2. Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer. Helpman L; Kupets R; Covens A; Saad RS; Khalifa MA; Ismiil N; Ghorab Z; Dubé V; Nofech-Mozes S Br J Cancer; 2014 Feb; 110(3):609-15. PubMed ID: 24366295 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry and Next-generation Sequencing Are Complementary Tests in Identifying PTEN Abnormality in Endometrial Carcinoma Biopsies. Wang L; Piskorz A; Bosse T; Jimenez-Linan M; Rous B; Gilks CB; Brenton JD; Singh N; Köbel M Int J Gynecol Pathol; 2022 Jan; 41(1):12-19. PubMed ID: 33720084 [TBL] [Abstract][Full Text] [Related]
4. Accuracy of preoperative endometrial sampling diagnosis for predicting the final pathology grading in uterine endometrioid carcinoma. Batista TP; Cavalcanti CL; Tejo AA; Bezerra AL Eur J Surg Oncol; 2016 Sep; 42(9):1367-71. PubMed ID: 27052799 [TBL] [Abstract][Full Text] [Related]
5. Agreement Between Preoperative Endometrial Sampling and Surgical Specimen Findings in Endometrial Carcinoma. Garcia TS; Appel M; Rivero R; Kliemann L; Wender MC Int J Gynecol Cancer; 2017 Mar; 27(3):473-478. PubMed ID: 28187097 [TBL] [Abstract][Full Text] [Related]
6. Impact of TP53 immunohistochemistry on the histological grading system for endometrial endometrioid carcinoma. Yano M; Ito K; Yabuno A; Ogane N; Katoh T; Miyazawa M; Miyazawa M; Hasegawa K; Narahara H; Yasuda M Mod Pathol; 2019 Jul; 32(7):1023-1031. PubMed ID: 30742011 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens. Chapel DB; Yamada SD; Cowan M; Lastra RR Gynecol Oncol; 2018 Jun; 149(3):570-574. PubMed ID: 29656794 [TBL] [Abstract][Full Text] [Related]
12. Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma. Hu S; Hinson JL; Matnani R; Cibull ML; Karabakhtsian RG Mod Pathol; 2018 Feb; 31(2):358-364. PubMed ID: 28984301 [TBL] [Abstract][Full Text] [Related]
13. Endometrial metaplasia: correlation of histological and cytological specimens obtained from 103 cases undergoing hysterectomy for endometrial carcinoma. Toomine Y; Watanabe S; Ohishi Y; Tamiya S; Sugishima S; Kobayashi H; Oda Y; Kaku T Cytopathology; 2014 Apr; 25(2):78-85. PubMed ID: 23517058 [TBL] [Abstract][Full Text] [Related]
14. Histotype-genotype correlation in 36 high-grade endometrial carcinomas. Hoang LN; McConechy MK; Köbel M; Han G; Rouzbahman M; Davidson B; Irving J; Ali RH; Leung S; McAlpine JN; Oliva E; Nucci MR; Soslow RA; Huntsman DG; Gilks CB; Lee CH Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778 [TBL] [Abstract][Full Text] [Related]
15. How challenging could be preoperative and intraoperative diagnosis of endometrial cancer? Ferrero A; Attianese D; Villa M; Ravarino N; Menato G; Volpi E Minerva Obstet Gynecol; 2023 Aug; 75(4):365-370. PubMed ID: 35191637 [TBL] [Abstract][Full Text] [Related]
16. Role of Immunohistochemistry to Distinguish Grade 3 Endometrioid Carcinoma and Uterine Serous Carcinoma. Zaidi A; Gupta P; Gupta N; Rajwanshi A; Rai B; Gainder S Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):42-48. PubMed ID: 31815745 [TBL] [Abstract][Full Text] [Related]
17. Complete Histologic Regression of Endometrioid Adenocarcinoma on Endometrial Biopsy After Progestin Treatment Does Not Guarantee the Regression of an Invasive Carcinoma Within the Myometrium. Park JY; Park JY; Nam JH; Kim KR Int J Gynecol Pathol; 2019 Jan; 38(1):66-70. PubMed ID: 29257040 [TBL] [Abstract][Full Text] [Related]
18. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists. Soslow RA; Tornos C; Park KJ; Malpica A; Matias-Guiu X; Oliva E; Parkash V; Carlson J; McCluggage WG; Gilks CB Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S64-S74. PubMed ID: 30550484 [TBL] [Abstract][Full Text] [Related]
19. Correlation between pre-operative and final histological diagnosis on endometrial cancer. Shiozaki T; Miwa M; Sakuma T; Suzuki K; Kogiku A; Yamamoto K; Senda T; Yano H; Kitai M; Matsuoka K; Sudo T; Nagao S; Yamaguchi S Int J Gynecol Cancer; 2019 Jun; 29(5):886-889. PubMed ID: 30826751 [TBL] [Abstract][Full Text] [Related]
20. Molecular classification of endometrial carcinoma applied to endometrial biopsy specimens: Towards early personalized patient management. Abdulfatah E; Wakeling E; Sakr S; Al-Obaidy K; Bandyopadhyay S; Morris R; Feldman G; Ali-Fehmi R Gynecol Oncol; 2019 Sep; 154(3):467-474. PubMed ID: 31248668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]